An underground market for unapproved weight-loss medications is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Experimental Drug Acquiring Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to message these profiles directly for supplier links, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Worries
However, doctors and pharmacists have cautions that the sale of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting products of unknown origin.
Several experts stated the demand for the experimental drug could be connected to the rising price of licensed slimming products such as Mounjaro.
Legal Status and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the British medical regulations.
Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.
Platform Reaction and Content Removal
Based on TikTok, the service has taken down problematic material and banned related keywords and query recommendations. The company said it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Digital Trading Activities
Investigations also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, filled with photos of slimming results, glowing testimonials and detailed guides for mixing or administering at residence.
After moments of entering one community, a vendor posted contact information, where most transactions occur. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.
Item Information and Pricing
Within these groups, messages display dark colored packages with postal service stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how much time a pen should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for the messaging service stated it regularly moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are injecting substances they can’t verify. Although the science behind retatrutide is sound, these digital products may not include what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her team has already seen patients harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental substance not yet approved … may expose users to possibly serious medical dangers”.
